With semaglutide and tirzepatide dosed once weekly, their estimated average yearly costs in the U.S. are $14,080 and $8,126, ...

Over a median follow-up of 7 years, breast cancer survivors had an 8% lower risk of Alzheimer's dementia compared with ...

Manav Midha is an MD candidate at the Icahn School of Medicine at Mount Sinai and a researcher at the USC Schaeffer Center ...

An often cited example of the importance of including a wide sample of patients is research showing that certain drugs can be ...

Note that some links may require registration or subscription. Three people died and 16 have been hospitalized in a listeria ...

The FDA approved dupilumab (Dupixent) as the first targeted drug for bullous pemphigoid, a rare blistering skin disease that ...

The 7-2 opinion comes as companies push back against a yearslong federal regulatory crackdown on electronic cigarettes. It's ...

A federal court has temporarily blocked the Trump administration from clawing back millions in public health funding from four Democrat-led municipalities in GOP-governed states. It's the second such ...

The news comes amid concerning trends in U.S. alcohol consumption and associated health risks, including an alarming surge in alcohol-related hospitalizations and liver transplants in younger ...

The FDA approved tafasitamab (Monjuvi) in combination with lenalidomide (Revlimid) and rituximab for relapsed or refractory follicular lymphoma. But the agency declined to expand the indication of ...

The exact reasons for this increased risk are not entirely clear but may be associated with lower CD4 cell counts, increased viral loads, and an increased prevalence of smoking. Additionally, people ...